In neuroblastoma cells, overexpression of SPARC can inhibit endothelial cell formation and cell proliferation, including induction of programmed cell death and the inhibition of angiogenic factors expression, such as FGF VEGF, PDGF, and MMP-9 in endothelial cells [49]. The gene discussed is SPARC; the disease is neuroblastoma.